Hee-Sook Jun
10Patents
3h-index
21Co-inventors
60Inventor score
Filing activity: Dec 4, 1996 → Nov 26, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5869060A | Portulaca oleracea and tumor cell growth | Human Necessities | 21 | Expired |
| US6551627B1 | Medicinal herbal compounds for the prevention and treatment of diabetes | Human Necessities | 17 | Expired |
| US6365727B1 | DNA and peptides of a diabetes-specific endogenous retrovirus | Chemistry; Metallurgy | 8 | Expired |
| US6770307B2 | Medicinal herbal compounds for the prevention and treatment of diabetes | Human Necessities | 1 | Expired |
| US6991792B2 | Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase | Chemistry; Metallurgy | 0 | Expired |
| US12208098B2 | 4-carbonylamino-4-phenylpyrimidine compound or pharmaceutically acceptable salt thereof | Chemistry; Metallurgy | 0 | Active |
| US7919080B2 | Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity | Chemistry; Metallurgy | 0 | Active |
| US10993993B2 | Pharmaceutical composition for treating muscle atrophy or sarcopenia including glucagon-like peptide (GLP-1) or GLP-1 receptor agonist | Chemistry; Metallurgy | 0 | Active |
| US10751392B2 | Pharmaceutical composition for treating sarcopenia including glucagon-like peptide-1 receptor agonist | Human Necessities | 0 | Active |
| US7312077B2 | Insulin-secreting immortalized liver cell line modified by glucose sensitivity | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.